Moshe Mittelman

10PUBLICATIONS
54CO-AUTHORS
Social epidemiologyRespiratory diseasesMedical mycologyRegenerative medicine (incl. stem cells)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 30, 2026
The Predictive Value of Serum Erythropoietin Levels Measured at Diagnosis in Patients With Myelodysplastic Syndromes.

|Feb 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategies.

Aleksandar Savic, Adele Taylor, Pierre Fenaux

|Aug 04, 2025
A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery.

Marco Roncador, Elsa Bernard, Robert Hasserjian

|Jun 17, 2025
Can we identify individuals at risk to develop multiple myeloma? A machine learning-based predictive model.

Moshe Mittelman, Ariel Israel, Howard S Oster

|Feb 19, 2025
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT.

Carmelo Gurnari, Marie Robin, Lionel Adès

|Jun 17, 2024
Roxadustat versus placebo for patients with lower-risk myelodysplastic syndrome: MATTERHORN phase 3, double-blind, randomized controlled trial.

Moshe Mittelman, David H Henry, John A Glaspy

Pageof 2

Frequent Collaborators

4 joint publications

Luca Malcovati

3 joint publications

Pierre Fenaux

3 joint publications

Argiris Symeonidis

3 joint publications

Saskia Langemeijer